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1. Introduction 
It is well known that the heart generates and conducts electrical impulses, leading to a 
rhythmical contraction of the cardiac muscle. In normal situations, the atria contract about 
one sixth of a second ahead of ventricular contraction, allowing the filling of the ventricles 
before they pump the blood through the lungs and peripheral circulation. Additionally, all 
portions of the ventricles contract almost simultaneously, which is essential for a most 
effective pressure generation in the ventricular chambers. This rhythmical and conductive 
system is susceptible to damage by heart disease, especially by ischemia of the cardiac 
tissues. The result is often an abnormal heart rhythm and sequence of contraction of the 
heart chambers, leading to a reduction in pumping effectiveness, even to the extent of 
causing death (Hall, 2011). 
Heart rate (HR) is not a static hemodynamic parameter but instead changes over time in 
response to physical and mental demands. HR is normally determined by spontaneous and 
periodic depolarizations of the sinoatrial node, the frequency of which is modulated by the 
sympathetic and parasympathetic divisions of the autonomic nervous system, the intrinsic 
cardiac nervous system, reflexes, and respiration. These neural systems also partially control 
cardiac contractility and conduction of electrical activity through the heart. As a result, HR 
(chronotropism), contractility (inotropism), and conduction (dromotropism) are adjusted to 
meet the changing needs of the body (Feldman et al, 2010).  
2. Electrical activity of the heart 
The properties of automaticity and rhythmicity are intrinsic to the cardiac tissue and 
considered a very complex phenomenon and, besides cellular mechanisms, integrative 
different factors are involved in cardiac pacemaking. The cardiac electrical events are 
initiated with changes in the permeability of the cell membrane, mainly to Na+, K+ and Ca2+ 
ions. Changes in cell membrane permeability alter the rate of ion passage across the 
membrane with the opening and closing of ion channels. Two main types of action 
potentials are observed in the heart: (A) fast action potentials, that occur in the normal 
myocardial fibers in the atria and ventricles and in the specialized conducting fibers 
(Purkinje´s fibers) and (B) slow action potentials, which are found in the sinoatrial (SA) 
node, the natural pacemaker of the heart, and in the atrioventricular (AV) node, the 
specialized tissue involved in conducting the cardiac impulse from atria to ventricles 
(Bouman and Jongsma, 1986). 
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In mammalian, the region of the heart that ordinarily generates impulses at the greatest 
frequency is the SA node. In humans, it lies in the groove where the superior vena cava joins 
the right atrium. It is a small, roughly rectangular region at the edge of the right atrium, 
bounded on two sides by the superior and inferior vena cava and on the other two by the 
interatrial septum and the crista terminalis, a part of the right atrial muscle over whose 
endocardial surface the pacemaking tissue of the SA node extends (Brown, 1982). The intact 
sinoatrial node is a heterogeneous structure and contains 2 principal types of cells: 1) small, 
round cells, which have few organelles and myofibrils; and 2) slender, elongated cells, 
which are intermediate in appearance between the round and the ordinary atrial myocardial 
cells. The round cells are probably the pacemaker cells, whereas the transitional cells 
probably conduct the impulses within the node and to the nodal margins (Verheijck et al., 
2011; Verheijck et al., 2004; Tellez et al, 2006).  
In the SA node cells, the upstroke of action potential is less steep, the plateau is not 
sustained and the depolarization is more gradual. However, the principal distinguish 
feature of a pacemaker resides in resting phase. In nonautonomic cells,  the resting potential 
is constant, whereas in a pacemaker fiber there is as low depolarization that proceeds at 
steady rate until a threshold is attained, and then an action potential is triggered (Brown, 
1982; Berne and Levy, 2009). In the pacemaker cells of the SA node the diastolic 
depolarization is attributed to at least 3 ionic currents: (1) an inward current (If), induced by 
hyperpolarization; (2) an inward Ca+2 current, (ICa); and (3) an outward K+ current, IK . The 
inward current (If) is carried mainly by Na+  and the current is conducted through specific 
channels that differ from the fast Na+ channels. This current becomes activated during the 
repolarization phase of the action potential, as the membrane potential becomes more 
negative than about -50mV. The more negative the membrane potential becomes at the end 
of repolarization, the greater is the activation of the If current. The second current 
responsible for diastolic depolarization is the slow inward current. This current is composed 
mainly of Ca+2 and therefore it is referred to as the Ca+2 current, (ICa). This Ca+2 current is 
carried mainly by T-type Ca+2 channels. Once the Ca+2 channels become activated, the influx 
of Ca+2 into the cell increases and accelerates the rate of diastolic depolarization, which then 
leads to upstroke of the action potential. The progressive diastolic depolarization mediated 
by the 2 inward currents, If and ICa, is opposed by a third current, an outward K+ current, IK . 
This efflux of K+ tends to repolarize the cell after upstroke of the action potential. The 
outward K+ current continues well beyond the time of maximum repolarization, but it 
diminishes throughout the end repolarization. Hence the opposition of IK to the 
depolarizing effects of the 2 inward currents (ICa and If) gradually decreases (Brown, 1982; 
Berne and Levy, 2009). 
From the SA node the cardiac impulse spreads radially throughout the right atrium along 
ordinary atrial myocardial fibers, at a conduction velocity of approximately 1m/sec. A special 
pathway, the anterior interatrial myocardial band, conducts the impulse from the SA node 
directly to the left atrium. Tree tracts, the anterior, middle, and posterior internodal pathways, 
constitute the principal routes to the conduction of the cardiac impulse from the SA to AV 
node. The AV node contains the same two cell types as the SA node, however the round cells 
are sparser and elongated cells preponderate. The AV node has been divided into three 
functional regions: 1) the AN region, the transitional zone between the atrium and the remnant 
node; 2) the N region, the midportion of the AV node; and 3) the NH region, the upper portion 
of the specialized conducting system for the ventricles. Usually, the AV node and the bundle 
of His constitute the only pathways to action potential conduction from atria to ventricles. The 
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conductive system passes subendocardially down the right side of the interventricular septum 
for about 1cm and divides into the right and left bundle branches. The right bundle branch is a 
direct continuation of the bundle of His and it proceeds down the right side of the 
interventricular septum. The left bundle branch, which is considerably thicker than the right, 
arises almost perpendicularly from the bundle of His and cross the interventricular septum. 
The right bundle branch and the two divisions of the left bundle branch ultimately subdivide 
into a complex network of conducting fibers called Purkinje´s fibers, which ramify over the 
subendocardial surfaces of both ventricles (Brown, 1982). 
In the myocardium, the action potential generation includes 5 distinct phases:  1) Phase 0: the 
chemical and electrostatic forces both favor the entry of Na+ into the cell through fast Na+ 
voltage-gated channels to generate the upstroke; 2) Phase 1: the chemical and electrostatic 
forces both favor the efflux of K+ through transient outward current (Ito) channels to generate 
early, partial repolarization; 3) Phase 2: during the plateau, the net influx de Ca2+ through L-
type Ca2+ voltage-gated channels is balanced by the efflux of K+ through rectifier (Ik), inwardly 
rectifying (Ik1) and Ito channels;  4) Phase 3: the chemical forces that favor the efflux of K+ 
through  Ik, Ik1,Ito channels predominate over the electrostatic forces that favor the efflux of K+ 
through these same channels; 5) Phase 4: the chemical forces that favor the efflux of K+ through  
Ik and Ik1 channels exceed very slightly the electrostatic forces that favor the influx of K+ 
through these same channels (Berne and Levy, 2009).  
3. Neural control of HR 
The peripheral circulation distributes the cardiac output to the various organs and tissues 
according to their individual metabolic or functional needs while maintaining arterial blood 
pressure within a relatively narrow range. Regional blood flows can be efficiently regulated 
at the local level by the intrinsic ability of vessels to respond to various mechanical forces 
(e.g., wall tension and shear stress) as well as chemical stimuli (e.g., tissue metabolites and 
O2). However, a perfect regulation of the peripheral circulation cannot be achieved only by 
the local vascular control mechanisms, but require the coordinating activity of central neural 
outflow to the heart and blood vessels (Thomas, 2011). In this field, the autonomic nervous 
system plays an important role to normal cardiovascular control and changes in autonomic 
balance has been related to several cardiovascular disorders, such as cardiac arrhythmias 
and hypertension (Workman, 2010; Pagani and Lucini, 2001). 
3.1 The autonomic nervous system and cardiovascular control  
The autonomic nervous system is responsible for the involuntary control of most visceral 
organs, including the heart and the interactions between the sympathetic and 
parasympathetic limbs play a critical role in cardiac electrical stability and arrhythmias 
generation. In general, sympathetic activation has a profound arrythmogenic potential 
(Schwartz et al., 1978, Schwartz 1984). Experimental stimulation of sympathetic nerves or 
stellate ganglia induces ECG repolarization changes and reduces the fibrillation threshold, 
facilitating ventricular fibrillation (Yanowitz et al, 1966; Podrid et al, 1990), while the use of 
┚-adrenergic blocking agents can improve survival in patients following myocardial 
infarction (Gottlieb et al, 1998). On the other hand, vagal activation has a powerful 
antifibrillatory effect (Vanoli et al., 1991; De Ferrari et al., 1994).  Therefore, autonomic 
imbalance could become either proarrythmic or anti-arrythmic based on which of the two 
components is going to prevail (Schwartz and De Ferrari, 2011).  
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Preganglionic fibers of autonomic nervous system are originated from central nervous 
system (CNS) at the level of the brainstem or sacral spinal cord (parasympathetic fibers) and 
the thoracic or lumbar spinal cord (sympathetic fibers). Both parasympathetic and 
sympathetic preganglionic fibers release acetylcholine which binds to nicotinic receptors 
located in the cell bodies of postganglionic neurons, leading to action potential generation. 
This synapse occurs in autonomic ganglia located outside of the CNS (Thomas, 2011). 
The axons of postganglionic neurons innervate the effector tissues, including cardiovascular 
tissues. Parasympathetic neurons are distributed much more heterogeneously throughout 
the heart than sympathetic neurons. The density of parasympathetic innervation in the 
sinoatrial (SA) and AV nodes is considerably higher than in the surrounding atrial or 
ventricular tissue (Vaseghi and Shivkumar, 2008). Cardiac sympathetic innervation of the 
heart includes innervation of the SA node and myocardial cells. Based on norepinephrine 
content studies, a gradient exists in sympathetic innervation from atria to ventricles and 
from base to apex of the heart, indicating that the atria are most densely innervated, but the 
ventricles are also supplied with a sympathetic network, most densely at the base (Vaseghi 
and Shivkumar, 2008). Regarding the neurotransmitters, postganglionic parasympathetic 
fibers release acetylcholine, which binds to muscarinic receptors on the target tissue, while 
postganglionic sympathetic fibers release norepinephrine, which binds to either ┙ or ┚ 
adrenergic receptors (Thomas, 2011). 
The effects of sympathetic and parasympathetic neurons on HR will be based on changes in 
the ion currents of SA node action potential generation. Norepinephrine release from post 
ganglionic sympathetic neurons will increase the slope of diastolic depolarization in SA 
node by the enhancement of the resting potential, while acetylcholine release from 
parasympathetic postganglionic neurons will decrease the slope of diastolic depolarization 
by hyperpolarization of the resting potential (Verrier and Tan, 2009). Additionally, 
sympathetic stimulation increases the rate of conduction as well as the level of excitability in 
all portions of the heart and augments greatly the force of contraction of all the cardiac 
musculature. Maximal stimulation can almost triple the frequency of heartbeat and can 
increase the strength of heart contraction as much as twofold. On the other hand, 
parasympathetic stimulation to the heart decreases the excitability of the A-V junctional 
fibers between the atrial musculature and the A-V node, thereby slowing the transmission of 
the cardiac impulse into the ventricles (Guyton and Hall, 2006). 
Given the ability to modulate both HR and stroke volume, the autonomic nerves provide an 
important mechanism to rapidly adjust cardiac output to meet short-term changes in the 
body’s needs (cardiovascular reflexes). In humans, there is a good deal of tonic vagal 
discharge and a moderate amount of tonic sympathetic discharge, showing a 
parasympathetic prevalence on the heart. Additional vagal discharge can further reduce HR, 
consequently cardiac output, whereas additional sympathetic discharge can increase HR 
and stroke volume and augment cardiac output. Conversely, withdrawal of tonic vagal or 
sympathetic discharge has opposing effects to increase or decrease cardiac output, 
respectively (Thomas, 2011). 
4. Cardiovascular reflexes 
It is well known that the maintenance of arterial pressure at adequate levels to perfuse the 
tissues is a basic requirement for survival. In cardiovascular system, among the mechanisms 
that act buffering arterial pressure fluctuations we can highlight the role of the neural 
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reflexes. Such control is an important pathway to effect rapid changes in blood pressure and 
in the distribution of cardiac output that are essential to maintain a sufficient perfusion to 
vital organs, such as heart, brain and the kidney in face of physiological and environmental 
challenges. This rapid control of cardiovascular function is achieved through arterial and 
non-arterial reflexes that detect and correct changes in arterial blood pressure (baroreflex), 
blood volume (cardiopulmonary reflex) or chemical composition (chemoreflex) of the blood 
(Vasquez et al., 1997). It is important to notice that the effectiveness of these systems may be 
modulated by hormonal systems, such as angiotensin II and nitric oxide. The understanding 
of the key concepts about these reflexes under physiological conditions and the effects of 
hormonal substances on its functioning is an important step to clarify the development of 
arrhythmias. 
4.1 Baroreflex 
The baroreflex feedback loop is one of the most important mechanisms controlling arterial 
pressure. The main purpose of the baroreflex function is to provide a rapid and efficient 
stabilization of arterial blood pressure on a beat-to-beat basis by means of strategically 
located arterial sensors which are sensitive to high blood pressure and known as arterial 
baroreceptors. The baroreceptors endings are located in adventitia layer of carotid sinus and 
aortic arch with their soma located in the petrosal and nodose ganglia respectively. These 
receptors are mechano-sensitive and the distension of the vessels that occurs at each heart 
beat leads to action potential generation on these terminals which are transmitted to CNS, 
buffering arterial pressure fluctuations through changes in sympathetic and 
parasympathetic activity (Vasquez et al., 1997). 
To achieve this precise control, the generated action potentials in each systole travel 
centrally to synapse onto neurons in the nucleus tractus solitarii (NTS) in the dorsal 
medulla. NTS neurons project to “higher” brain nuclei, as well as other nuclei in  
the brainstem that are critical for efferent sympathetic and parasympathetic activity 
(Loewy and Spyer, 1990). Projections from NTS are connected to the inhibitory neurons of 
caudal ventrolateral medulla (CVLM) that subsequently synapse to excitatory neurons  
in the rostral ventrolateral medulla (RVLM). RVLM exerts a tonic discharge upon  
the preganglionic sympathetic neurons, located in the intermediolateral column (IML) of 
the spinal cord (Kirkman and Sawdon, 2004). Therefore, activation of the baroreceptor 
afferents innervating the NTS causes excitation of neurons projecting to the CVLM,  
which in turn inhibits RVLM. These events lead to less activity from the RVLM to IML, 
reducing sympathetic efferent activity (Figure 1A). Several studies have demonstrated 
that disturbances in the normal functioning of these nuclei can be related to the 
development of arrhythmias. In example, Issa et al. (2005) showed that the central 
inhibition of the sympathetic drive using clonidine reduces the occurrence of ventricular 
tachycardia/ventricular fibrilation in a canine heart failure model. 
In parallel, NTS neurons also synapse onto preganglionic vagal neurons localized within 
nucleus ambiguus (NA) and in the dorsal motor nucleus of the vagus (DMNX, Figure 1A). 
These neurons dominate the neural control of HR under normal conditions and also influence 
the prognosis of many cardiovascular disorders, such as sudden cardiac death, ventricular 
fibrillation, and myocardial ischemia (Wand et al, 2001). The axons from preganglionic cardiac 
vagal neurons travel down the vagus nerve and synapse onto postganglionic cardiac vagal 
neurons in cardiac ganglia. The synaptic innervation of cardiac vagal neurons is therefore 
critical for the tonic and reflex evoked changes in cardiac vagal activity that control HR. 
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Fig. 1. Schematic diagram showing the baroreflex functioning during normal (A), increased (B) 
and decreased blood pressure (C). NTS: nucleus tractus solitarii, NA: nucleus ambiguus, 
DMNX: dorsal motor nucleus of the vagus, CVLM: caudal ventrolateral medulla,  
RVLM: rostral ventrolateral medulla, IML: intermediolateral column, PSNS: parasympathetic 
nervous system, SNS: sympathetic nervous system, BP: blood pressure. The continuous arrow 
and the dashed arrows indicate a stimulatory and an inhibitory synapse, respectively. 
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Therefore, when blood pressure rises, the baroreceptor afferent activity augments, leading to 
increased vagal activity and diminished sympathetic outflow. These effects will reduce HR 
and cardiac contractility, causing a decrease in cardiac output. Additionally, the fall the 
sympathetic activity to blood vessels also leads to vasodilation, diminishing the vascular 
resistance (Figure 1B). The reduced cardiac output and vascular resistance return blood 
pressure to its original level.  On the other hand, a fall in blood pressure results in reduced 
baroreceptor afferent activity, causing a decrease in vagal activity and augmented 
sympathetic outflow (Figure 1C). These events increase cardiac output and vascular 
resistance, normalizing arterial blood pressure. 
Experimentally, the baroreflex function can be evaluated through changes in arterial 
pressure. In bolus phenylephrine injections elicits increases in arterial pressure leading  
to reflex bradycardia and sodium nitroprusside injections reduces arterial pressure 
causing reflex tachycardia. Typical recordings of baroreflex evaluation are displayed in 
Figure 2. 
4.2 Cardiopulmonary reflex 
Despite the great importance of baroreflex in controlling arterial pressure, several 
investigations have demonstrated that the neural reflex of circulation also depends on 
cardiopulmonary reflex. 
Cardiopulmonary receptors are found in low pressure portions of the circulation, such as 
walls of the atria and pulmonary arteries. These mechano-sensitive receptors are activated 
by the distension of the vessels walls, responding to changes in central blood volume 
(Thomas, 2011). The impulses arising from these receptors exert a tonic restraint on 
cardiac function and contribute to the physiological control of circulation. 
Cardiopulmonary reflexes are stimulated not only by changes in cardiac filling pressure 
but also by chemical agents, such as prostaglandins and serotonin (Vasquez et al., 1997). 
The cardiopulmonary fibers converge to the same pool of central neurons as the 
baroreceptors and act in a similar way (Spyer, 1990). Therefore, increased discharge of 
cardiopulmonary vagal afferent C fibers results in reflex enhancement of parasympathetic 
activity and decreased sympathetic outflow, leading to bradycardia, hypotension and 
apnea, also known as the Bezold-Jarisch reflex (BJR) (Kashihara, 2009). In addition, 
increased discharge of the cardiopulmonary receptors diminishes renal sympathetic 
outflow and pituitary release of vasopressin, thereby decreasing Na+ and water 
reabsorption by the kidneys, increasing urine volume, and reducing blood volume. As 
changes in blood volume affect cardiac output and arterial pressure, this provides an 
additional mechanism by which the cardiopulmonary reflex contributes to blood pressure 
regulation (Thomas, 2011). 
Interestingly, cardiopulmonary reflex may exert a tonic inhibitory influence in the arterial 
baroreflex sensitivity (Abboud and Thames, 1983). In pathological conditions, such as acute 
myocardial infarction, the reduction in baroreflex sensitivity could be explained by an 
increase in cardiopulmonary reflex sensitivity (Lacerda et al., 2007). Furthermore, the BJR 
activation might cause sudden cardiac death during ischemic injury (Robertson et al., 1985), 
since the overactivation of cardiopulmonary reflex together with baroreflex blunting might 
cause severe bradycardia and hypotension, placing the patient's life at risk due to the 
magnitude of sympathetic inhibition and vagal activation. These data demonstrate that the 
interplay between baroreflex and cardiopulmonary reflex may exert an important role in the 
progression of cardiovascular diseases and arrhythmias generation. 
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Fig. 2. Typical recordings of baroreflex evaluation in anesthetized rats. The phenylephrine-
induced increase in arterial pressure leads to reflex bradycardia (upper panel) and the 
sodium nitroprusside-induced decrease in arterial pressure results in reflex tachycardia 
(lower panel). The images were generously provided by Professor Helder Mauad from 
Federal University of Espirito Santo, Brazil. Data from Pedrosa et al., 2009. PAP: pulsatile 
arterial pressure, MAP: mean arterial pressure, HR: heart rate, PHE: phenylephrine, SNP: 
sodium nitroprusside. 
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Experimentally, the cardiopulmonary reflex function can be evaluated through 
phenylbiguanide injections. Figure 3 shows typical recordings of changes in arterial 
pressure and HR during cardiopulmonary reflex test. 
 
 
Fig. 3. Typical recordings of cardiopulmonary reflex evaluation in anesthetized rats.  
The activation of cardiopulmonary receptors is achieved by intravenous phenilbiguanide 
injections. The images were generously provided by Professor Helder Mauad from Federal 
University of Espirito Santo, Brazil. Data from Pedrosa et al., 2009. PAP: pulsatile arterial 
pressure, MAP: mean arterial pressure, HR: heart rate, PBG: phenybiguanide. 
4.3 Arterial chemoreflex 
The peripheral chemoreflex is considered one of the main mechanisms of control of the 
ventilatory responses to the changes in arterial O2 and CO2 concentrations. The peripheral 
chemoreceptors located in the carotid and aortic bodies, with afferents to the respiratory 
center in the medulla oblongata and the NTS, respond primarily to hypoxia (Guimarães et 
al., 2009). These chemo-sensitive receptors constantly receive information of arterial pO2, 
pCO2 e pH through a thin artery originated in the middle of the bifurcation of the common 
carotid artery that maintains these cells in close contact with blood gases (Vasquez et al., 
1997). Increases in the firing rate of these neurons lead to a simultaneously activation of 
sympathetic outflow to blood vessels and increased vagal activity to the heart (Kara et al., 
2003). Therefore, the excitation of the peripheral chemoreceptors produces an increased 
minute ventilation, systemic vasoconstriction and hypertension. The primary HR response 
to chemoreceptor stimulation is a parasympathetic mediated-bradycardia, but this 
mechanism is usually apparent only in the absence of ventilation. In the presence of the 
normal ventilatory response to hypoxia, tachycardia is generated by a lung inflation reflex 
that inhibits vagal outflow to the heart (Marshall, 1994). It is interesting to notice that, if 
blood pressure is within its normal range, the chemoreflex does not evoke a powerful 
cardiovascular response because of the predominant effect of the arterial baroreflex. 
www.intechopen.com
 
Cardiac Arrhythmias – New Considerations 
 
176 
However, if blood pressure is low, generally below 80 mmHg, activation of the chemoreflex 
potentiates the vasoconstriction evoked by the baroreflex and helps to restore blood 
pressure to normal (Thomas et al., 2011).  
The role of chemoreflex in cardiac arrhythmias have been already demonstrated. Patients 
with survived ventricular arrhythmias show significantly decreased chemoreflex sensitivity 
(Hennersdorf et al., 1997). The chemoreflex sensitivity is also considered as a marker of 
increased risk for ventricular tachyarrhythmias, since it shows a high positive predictive 
power in patients with prior myocardial infarction and who previously survived ventricular 
tachyarrhythmias (Hennersdorf et al., 2002). Central sleep apnea, which is associated with 
absent respiratory effort and results from instability in the chemoreflex control of breathing, 
is thought to predispose to cardiac arrhythmias generation (Leung et al., 2009). 
Experimentally, the chemoreflex function can be evaluated through potassium cyanide 
injections. Figure 4 shows typical recordings of changes in arterial pressure and HR during 
chemoreflex test. 
 
 
Fig. 4. Typical recordings of chemoreflex evaluation. The activation of chemoreflex  is 
achieved by intravenous potassium cyanide injections. The images were generously 
provided by Professor Helder Mauad from Federal University of Espirito Santo, Brazil. Data 
from Pedrosa et al., 2009. PAP: pulsatile arterial pressure, MAP: mean arterial pressure, HR: 
heart rate, KCN: potassium cyanide. 
5. Humoral control of HR 
Several investigations have demonstrated that humoral systems can play a pivotal role in 
maintaining cardiac electric activity homeostasis and changes in their production and/or 
action pathways may contribute to various disorders in cardiac excitability. Additionally, 
the humoral systems can also modulate the autonomic nervous system and cardiovascular 
reflexes, demonstrating the importance of these substances in cardiovascular functioning.  
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5.1 Estrogen 
The sexual hormones are related mainly with the control of reproductive function, however 
they can also modulate the cardiovascular function. Estrogen is the main female sex 
hormone in both humans and animal models. It is produced in the granulosa cells of the 
ovarian cortex through the conversion of androgen precursors by the aromatase enzyme, 
which in turn is modulated by the hormonal hypothalamic-pituitary axis (Filicori, 1986). The 
protective effects of estrogen on cardiovascular function have been already demonstrated by 
several investigations. Indeed, estrogen replacement therapy reduces the incidence of 
coronary artery disease (Rowland & Fregly, 1992; Farhat et al., 1996). Corroborating these 
data, Moyses et al. (2001) showed that estrogen treatment in ovariectomized female rats 
restored coronary vasodilation produced by serotonin in isolated hearts, and a bolus 
injection of 17ß-estradiol elicited a transient vasodilatory response in male and female 
normotensive (Santos et al., 2004) and spontaneously hypertensive rats (Santos et al., 2010). 
It has been already demonstrated that estrogen levels are also related with the development 
of cardiac arrhythmias. During the menstrual cycle, estrogen levels rise and fall in women 
and these fluctuations are related with more frequent episodes with a longer duration of 
supraventricular tachycardia (Rosano et al., 1996). During perimenopause there is a marked 
decrease in ovarian estrogen production that is associated with an increase in HR (sinus 
tachycardia) and an enhancement in the frequency of palpitations and non-threatening 
arrhythmias, such as premature ventricular contractions (Rosano et al., 1996; Asplund and 
Aberg, 2003). During menopause a further decline in estrogen occurs and this event is 
associated with irregular heartbeats, palpitations, spasmodic chest pain and nightmares in 
women from 40 to 64 years old (Asplund and Aberg, 2003). Corroborating this data, 
hormonal replacement therapy (HRT) may decrease palpitations and other symptoms such 
as hot flashes, insomnia, and sweating (Grady et al., 2002). On the other hand, the Heart and 
Estrogen/Progestin Replacement Study (HERS) found no benefit to reduce cardiovascular 
events in women on HRT, which may even increase risk of thromboembolism during the 
first year (Grady et al., 2002). HRT has also being associated with lengthening the QT 
interval, although the relevance of this finding is not known (Gokce et al., 2005). Therefore, 
more investigations are necessary to better elucidate the benefits of HRT in preventing 
cardiac arrhythmias generations.   
The mechanisms by which estrogen may affect the development of cardiac arrhythmias 
include changes ion channels expression and/or activity. Most of the studies demonstrate 
that estrogen exerts antiarrhythmic effects, possibly by acting the L-type Ca2+ channels, 
contributing to its cardioprotective actions (Nakajima et al., 1999). Ulrich et al (2007) 
demonstrated that estrogen inhibits ICaL through direct interactions of the steroid with the 
channel protein in a rate dependent way, leading to a decreased contraction.  However, 
estrogen can also upregulates the sodium-calcium exchanger (NCX1) through a genomic 
mechanism mediated by estrogen receptors (ER), contributing to the enhanced propensity to 
early after depolarizations in female hearts (Cheng et al 2011). 
It is well established that estrogen can cross the blood brain barrier and be accumulated in 
regions of the brain to bring about changes in neural activity, including in autonomic 
functions (Lee and McEwen, 2001). This modulation may occur via activation of ERs, since 
ER mRNAs expression have been identified in central areas controlling cardiovascular 
function such as, NTS, CVLM, RVLM and IML (Spary et al, 2009).  
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Several studies have demonstrated the effects of estrogen on cardiovascular reflexes. In 
ovariectomized female rats, intravenous estrogen supplementation significantly reduced 
sympathetic tone within 30 minutes and significantly increased parasympathetic tone 
within 5 minutes of administration (Saleh and Connel, 2000). Corroborating these 
findings, Flues et al (2010) demonstrated that ovariectomized rats supplemented with 17┚ 
estradiol presented an exacerbated vagal tonus when compared to ovariectomized rats. 
This study also showed that ovarian hormones deprivation induced a higher sympathetic 
activity to the heart. Additionally, Minson et al (2000) reported an increase of baroreflex 
sensitivity (BRS) in phases of menstrual cycle with estrogen preponderance. An enhanced 
BRS is associated with an increase in parasympathetic and/or a decrease in sympathetic 
tone (Rovere et al, 2000), and the degree of BRS depression is significantly correlated to an 
increased likelihood of cardiac arrhythmogenesis (Saleh et al, 2003). Taken together, those 
data indicate a beneficial effect of estrogen in autonomic balance and in arrhythmias 
prevention. 
5.2 Testosterone 
Testosterone, the major androgenic hormone is synthetized and released by the Leydig cells in 
the testis. It also gives rise to two other potent androgens: dihydrotestosterone and 5-alfa-
androstenediol. Epidemiological and clinical studies indicate that testosterone status influence 
cardiovascular physiology and pathophysiology (Golden et al., 2002; Er et al., 2007). 
The effects of testosterone on cardiac electric activity have been poorly investigated. Sanchez 
et al. (2009) showed that the acute administration of 5-alpha-dihydrotestosterone elicited a 
negative chronotropism effect and increased SA node recovery time, which could improve 
cardiac performance. The authors also suggested that this effect might be due to an 
interaction with the underlying mechanisms involved in the pacemaker activity (Mangoni 
and Nargeot, 2008) such as T-type Ca2+ channel and inward rectifier currents and a 
functional interaction with ionic pumps of plasma membranes. On the other hand, the acute 
treatment with testosterone enhanced the spontaneous beating frequency of cultured 
neonatal cardiomyocytes, which was associated with an increase in the level of expression of 
T-type Ca2+ channels (Michels et al., 2006).  It has also been reported that androgens produce 
changes in the male heart phenotype and on electrophysiological properties, such as 
shortening of the QT interval in males after puberty (Rautaharju, 1992; Lehmann, 1997; 
Locati et al., 1998). These contradictory data may be related to different basal HR values 
among various mammalian species, and more studies are necessary to better elucidate the 
role of testosterone on cardiac electric activity. 
Most of the research concerning the effects of gonadal hormones on the cardiovascular 
reflexes has focused on 17┚-estradiol. However, other studies have provided evidence 
that androgens (including testosterone) play an important role in the control of 
cardiovascular function by modulation of cardiovascular reflexes (Caminiti et al., 2009). 
Steroids can cross the blood–brain barrier and act on the central nervous system, where 
androgen receptors in the central cardiovascular regulatory regions, such as NA and 
DMNX (Peuler et al., 1990; Pouliot et al., 1996) have been demonstrated. Therefore it is 
possible that androgens may act on brainstem vagal preganglionic neurons to modulate 
cardiomotor vagal activity. In accordance with this data, El-Mass et al. (2001) have shown 
that in male rats, castration caused a significant attenuation of baroreceptor control of 
reflex bradycardia versus no effect on reflex tachycardia. Testosterone replacement 
increased BRS to phenylephrine in castrated rats and restored reflex bradycardic 
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responses to levels similar to those of sham-operated rats. The muscarinic blockade by 
atropine in sham-operated rats caused a substantial reduction in BRS to phenylephrine, an 
effect that was significantly attenuated by castration and restored to sham-operated levels 
after testosterone replacement, suggesting that testosterone facilitates baroreceptor 
control of reflex bradycardia. Moreover, the modulatory role of testosterone on baroreflex 
responsiveness appears to involve, at least partly, enhancement of cardiac vagal efferent 
activity. Corroborating these data, a long-term testosterone therapy (6 weeks) improves 
the baroreflex sensitivity in men with chronic heart failure (Caminiti et al., 2009). The 
blockade of androgen receptor with flutamide attenuates the enhancement of baroreflex 
bradycardia in sexually mature male rats, indicating that the effects of testosterone on 
BRS depend on the involvement of the androgen receptor (Ward and Abdel-Rahman, 
2006). 
Besides the testosterone-induced effects on baroreflex, this sexual hormone may also 
modulate the cardiopulmonary reflex and the chemoreflex. Bissoli et al (2009) demonstrated 
that long-term treatment (8 weeks) with supraphysiological doses of nandrolone decanoate 
reduces the sensitivity of BJR control of HR in male rats. The effects of testosterone on BJR 
seem to be time-dependent, since the same treatment for 4 weeks had no effects on BJR nor 
the basal HR (Andrade et al., 2008). Pereira-Junior et al. (2006) showed that 10 weeks of 
high-dose nandrolone decanoate treatment leads to dysfunction in tonic cardiac autonomic 
regulation, with marked impairment of parasympathetic cardiac modulation and 
sympathetic hyperactivity. Regarding the chemoreflex, data from castrated male cats 
suggest that testosterone increases the hypoxic and hypercapnic ventilatory responses and 
augmented carotid body sensitivity to hypoxia (Behan et al., 2003). In adult rats, however, 
castration had no effect on the ventilatory response measured at the end of hypoxia (Joseph 
et al., 2002). On the other hand, Bairam et al. (2009) demonstrated that gonadectomy 
increased the acute breathing frequency response to hypoxia in neonatal rats. Because the 
rapid increase in breathing frequency is attributed to peripheral chemoreceptor activation, 
these data suggest that testosterone attenuates carotid body function. Although several 
studies demonstrated contradictory results about the benefic or malefic effects of 
testosterone on the modulation of cardiovascular reflexes, the characterization of the 
mechanisms could lead to a better understanding of the effects of testosterone in 
cardiovascular system and to the development of new therapies. 
5.3 Nitric oxide (NO) 
Since the discovery of the signaling properties of nitric oxide (NO) (Ignarro et al. 1987), it 
has been suggested that this important molecule may be involved in many physiological 
processes, such as the control of cardiovascular function. NO is a free radical synthesized 
from L-arginine by three isoforms of nitric oxide synthase (NOS): NOS1 (neural), NOS2 
(inducible), and NOS3 (endothelial) and all three isoforms have been shown to influence 
autonomic neural function in some manner (Schultz, 2009).  NO generated at nerve synapses 
diffuses in an autocrine and paracrine way to influence both presynaptic and postsynaptic 
events on excitatory and inhibitory synapses. NO exerts its cellular actions by binding to  
guanylyl cyclase to activate cGMP production, which remains the only fully recognized 
physiological signal transduction mechanism for NO. In central neurons, cGMP then can 
have diverse effects on neuronal excitability. Cyclic GMP can directly bind to and modulate 
cyclic nucleotide-gated ion channels, bind to phosphodiesterases to impair cAMP 
hydrolysis, or most prominently, activate cGMP-dependent protein kinase which can 
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directly or indirectly leads to phosphorylation of effector proteins or ion channels (Schultz, 
2009). 
The effects of NO on baroreflex have been already demonstrated by several investigations. 
Meyrelles et al (2003) have shown that adenovirus-mediated eNOS delivery to carotid sinus 
adventitia leads to a diminished baroreceptor activity. NO seems to have an inhibitory effect 
on sodium currents in baroceptor neurons (Li et al., 1999) and activates calcium dependent 
potassium channels, leading to membrane hyperpolarization (Bolotina et al., 1994). 
Besides NO effects on baroreceptor afferents, NO also exerts effects on central nuclei 
regulating baroreflex function.  
Intracerebroventricular injections of L-NAME (an inhibitor of NO synthases) caused an 
enhancement in baroreflex sensitivity, indicating that NO may exert an inhibitory effect upon 
baroreflex (Matsumura et al, 1998). This inhibition appears to occur in both sympathetic and 
parasympathetic component of baroreflex. Liu et al (1996) demonstrated that NO synthase 
blockade with L-NNA causes an increase in the baroreflex gain, which is prevented by L-
arginine injections. This augmented sensitivity is blocked by the use of atropine, indicating an 
inhibitory effect of NO on the parasympathetic component of the reflex. NO also seems to 
exert sympatoinhibitory effects, as demonstrated by Zanzinger et al (1995) who show that L-
NNA administration leads to an increased basal sympathetic tonus. On the other hand, Dias et 
al. (2005) demonstrated a stimulatory effect of NO in the central nuclei controlling 
cardiovascular function. In this study, the renal sympathoinhibition induced by activation of 
baroreceptors and cardiopulmonary receptors is attenuated by the microinjection of L-NAME 
in the NTS.  The same investigators also demonstrated that NO increases the number of 
discharges evoked by excitatory amino acids in NTS neurons that receive vagal afferent inputs, 
and action potentials induced by iontophoretic application of AMPA in the NTS was reduced 
by L-NAME, indicating a excitatory effect of NO in this nucleus (Dias et al., 2003). Some 
studies also showed no effects of NO on baroreflex function. eNOS gene therapy did not alter 
baroreflex sensitivity and autonomic balance in C57 mice and was not able to prevent the 
increase in sympathetic tonus and the decrease parasympathetic activity to the heart in 
hypertensive mice (Gava et al., 2008). 
In addition to the brain, emerging evidence suggests that NO can also influence 
sympathovagal function at the site of the end-organ itself, acting in sympathetic ganglia or 
vagal neurons. Neuronal nitric oxide synthase is localized in both intrinsic cardiac vagal 
neurons and stellate sympathetic ganglia innervating the SA node, indicating an important 
role NO in modulating of peripheral neuronal function (Herring and Paterson, 2009). In 
cholinergic neurons, NO seems to act increasing acetylcholine release through stimulation of 
soluble guanylate cyclase. The resultant generation of cGMP causes phosphodiesterase-3 
inhibition, increasing cAMP-PKA dependent phosphorylation of N-type calcium channel and 
calcium-induced exocytotic release of acethycholine (Herring & Paterson, 2001). However, in 
the AV nodal cells, NO regulates AV excitabilility by muscarinic cholinergic attenuation of 
ICa-L (L-type calcium current), the mechanism likely involves the cGMP-stimulated 
phosphodiesterase (Han et al., 1997). In sympathetic ganglia, NO reduces the release of 
noradrenaline through a soluble guanylate cyclase–cGMP dependent pathway that reduces 
calcium influx (Schwartz et al. 1995; Wang et al. 2007), probably via stimulation of PDE2 
and/or protein kinase G (Herring and Paterson, 2009). Despite some contradictory results, the 
role of NO in the modulating HR it is well established and the implication of changes in the 
NO production and/or activity for cardiovascular disease development remains an intriguing 
possibility of new targets for treating arrhythmias.  
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5.4 Renin-angiotensin-aldosterone system (RAAS) 
The RAAS is a peptidergic cascade with endocrine characteristics and is considered one of 
the most important systems that participate of cardiovascular control. In the classical view 
of RAAS, angiotensinogen, an alfa-glycoprotein, is released from the liver and is cleaved in 
the circulation by the enzyme renin that is secreted from the juxtaglomerular apparatus of 
the kidney to form the decapeptide angiotensin I (Ang I). Ang I is then transformed into to 
the octapeptide angiotensin II (Ang II) by angiotensin converting enzyme (ACE), a 
membrane-bound metalloproteinase, which is predominantly expressed in high 
concentrations on the surface of endothelial cells in the pulmonary circulation. Ang II, 
considered the main effector peptide of the RAAS, acts on specific receptors (AT1 and AT2), 
for example, to induce vasoconstriction on vascular smooth muscle cells or to stimulate the 
release of aldosterone from the adrenal cortex (Paul et al., 2006). 
Several lines of evidence suggest that Ang II may exert a direct modulation on cardiac 
ionic channels. Experiments have shown that stimulation of AT1 receptor result in the 
inhibition of transient outward potassium channel in myocytes from rat or canine 
ventricle (Shimoni and Liu, 2003; Yu et al., 2000). Ang II also increases cardiac L-type Ca2+ 
current (ICaL) in isolated cat myocytes (Aiello and Cingolani, 2001). In this view, the 
RAAS activation may therefore significantly contribute to the pathogenesis of cardiac 
arrhythmias. On the other hand, Ang II decreased the current density of L-type Ca2+ 
current in SA node cells and reduces the auto rhythm of SA node cells via enhancing 
slowly activated delayed rectifier K+ currents and reducing ICaL. Therefore, the elevated 
levels of Ang II may be involved in the occurrence of SA node dysfunction in cardiac 
pathophysiology (Sheng et al., 2011). 
Numerous studies already demonstrated that Ang II plays a pivotal role in the neural 
regulation of cardiovascular system. High concentrations of AT1 receptor and fibers with 
Ang II immunoreactivity have been described in the dorsomedial and ventrolateral areas 
of the medulla (Allen et al., 1998; Averill and Diz, 2000). It is well known that Ang II 
causes an increased sympathetic drive, particularly by means of central mechanisms. In 
dogs, acute (21 h) and chronic (5 days) infusion of Ang II caused a two- to threefold 
increase in Fos-Li immunoreactivity in the NTS and CVLM, leading to a baroreceptor 
suppression of sympathoexcitatory cells in the RVLM (Lohmeier et al, 2002). Lesions at 
either the area postrema or the subfornical organ attenuate angiotensin II-based 
hypertension, indicating a direct central sympathoexcitatory action of Ang II (Collister 
and Hendel, 2003; Collister and Hendel, 2005). Corroborating these data, experimental 
models of angiotensin II-dependent hypertension present an augmented sympathetic 
drive (Peotta et al., 2007) and patients with chronic angiotensin-dependent renovascular 
hypertension have generally demonstrated higher sympathetic levels, correlated with 
circulating angiotensin II concentrations (Grassi e Esler, 2002). Besides Ang II effects on 
sympathetic drive, this peptide also exerts effects on the parasympathetic component of 
the reflexes. Borges et al. (2008) demonstrated that mice with renovascular hypertension 
presented diminished cardiac vagal activity, and together with an enhanced cardiac 
sympathetic activity, contributed to a reduced baroreflex sensitivity in this animal model 
of hypertension. Moyses et al. (1994) also demonstrated a reduced cardiac vagal activity in 
renovascular hypertensive rats.  
Although Ang II is considered the major effector of RAAS system, growing evidence have 
demonstrated an important role of angiotensin-(1-7) in cardiovascular regulation. This 
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molecule can be formed from Ang I and Ang II fragments through an angiotensin-
converting enzyme (ACE) independent pathway (Santos et al., 2007). It has been 
demonstrated that Ang-(1-7) actions are often contrary to those described for Ang II 
(Benter et al., 1993). In fact, regarding the neural control of circulation, several studies 
have provided evidence that endogenous Ang-(1-7) enhances the baroreceptor reflex 
bradycardia, while Ang II attenuates it (Campagnole-Santos, 1992; Sakima et al., 2007). 
The beneficial effect of Ang-(1-7) on cardiovascular reflexes was also demonstrated by 
Oliveira et al (1996) who showed that the central infusion of a selective Ang-(1-7) 
antagonist attenuates baroreflex and blocks the improvement in the reflex bradycardia 
produced by Ang-(1-7). The specific binding of Ang-(1-7) to its receptor (Mas receptor) 
seems to be a basic requirement for the maintenance of normal arterial blood pressure and 
cardiovascular reflex control, since Mas-knockout mice presented hypertension and 
altered cardiovascular reflexes (Moura et al., 2010). 
5.5 Natriuretic peptides (NPs) 
The NPs play an important role in the regulation of cardiovascular homeostasis 
maintaining blood pressure and extracellular fluid volume. There are four major 
natriuretic peptides (NPs) that have been isolated: atrial natriuretic peptide (ANP), brain 
natriuretic peptide (BNP), C-type natriuretic peptide (CNP), and Dendroaspis-type 
natriuretic peptide (DNP).  NPs exert their biological effects by binding to three distinct 
cell surface receptors denoted NP receptors A, B and C (NPR-A, NPR-B and NPR-C) (Rose 
and Giles, 2008).  
Several studies demonstrated that NPs affect the electrophysiology of the heart (Rose et al., 
2004) and central nervous system (Trachte et al., 2003; Rose et al., 2005). Voltage-clamp 
studies demonstrated that CNP can inhibit L-type Ca2+ current (ICa-L) through NPR-C 
binding. This inhibition involves a decrease in adenylyl cyclase activity, which leads to 
reduced intracellular levels of cAMP (Rose et al., 2003). These results were also 
demonstrated in isolated myocytes from mouse  SA node, that express several cAMP-
sensitive currents, including ICa-L (DiFrancesco, 1993). Corroborating these data, inhibition 
of adenylyl cyclase decreases HR and increases the P–R interval, suggesting that the 
atrioventricular conduction system is slowed following the activation of NPR-C. These data 
are consistent with other studies demonstrating a key role for L-type Ca2+ channels in the 
intrinsic regulation of SA node function and the determination of HR (Zhang et al., 2002; 
Mangoni et al., 2003). The molecular mechanism(s) by which CNP–NPR-C effects are 
compartmentalized in animal models SA node myocytes is not clear and will require further 
investigation. 
In addition to their effects on cardiac electric activity, NPs also exert effects on 
cardiovascular reflexes.  Thomas et al. (2001) showed that ANP, BNP and CNP enhance 
bradycardic responses to cardiopulmonary chemoreceptor activation in conscious sheep. 
On the other hand, Tallarida et al. (1991) demonstrated that intravenous infusion of ANP 
did not substantially change the baroreflex cardiocirculatory responses to loading and 
unloading carotid and aortic baroreceptors. Some of the reported discrepancies may be 
attributed to the dose of ANP, preparation (e.g., synthetic peptide vs. atrial extract) or to 
experimental conditions (e.g., anaesthetized vs. conscious). The target site(s) for the NPs 
action on cardio-cardiac vagal reflexes is not clear and more studies are necessary to 
better elucidate the mechanisms involved in NP-induced changes in cardiovascular 
reflexes.   
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5.6 Thyroid hormones (TH) 
Variations from euthyroid status affect virtually all physiological systems and the  effects on 
the cardiovascular system are particularly pronounced (Levey and Klein, 1990). 
Hyperthyroidism causes tachycardia and cardiac arrhythmias whereas bradycardia, 
reduced cardiac output, and slowed relaxation result from hypothyroidism (Klein and 
Ojamaa, 2001). The actions of TH are mediated by two nuclear TH receptors (TRs)- ┙ and- ┚, 
encoded by two separate genes (Yen, 2001). TR-┙1 isoform represents 70% of the TRs and 
serves an important role in cardiac development (Mai et al., 2004) and the regulation of 
heart rate and contractility (Dilmann, 2010; Macchia et al., 2001). Corroborating these data, 
Wikström et al. (1998) demonstrated that TR-┙1 knockout mice presented a 20% reduction in 
HR and a prolonged relaxation time. The molecular explanation for these results includes a 
diminished expression of the hyperpolarization activated cyclic nucleotide-gated potassium 
channel 2, which plays a pivotal role for pacemaking (Macchia et al., 2001). 
Changes in thyroid status are associated with changes not only in cardiac and vascular 
function but also in autonomic regulation of the cardiovascular system (Levey and Klein, 
1990). In example, Foley et al. (2001) evaluated the effect of thyroid status on arterial baroreflex 
control of lumbar sympathetic nerve activity (LSNA) and HR in conscious rats. The authors 
report that rats with hypothyroidism exhibit blunted baroreflex mediated increases in LSNA 
and HR and a downward shift in baroreflex control of HR compared with euthyroid rats. On 
the other hand, rats with hyperthyroidism presented normal baroreflex function and 
sympathetic tone to the vasculature. Although hypothyroidism has been associated with 
sympathovagal imbalance, current literature shows conflicting results with either increased 
sympathetic activity  (Cacciatori et al., 2000), decreased sympathetic modulation (Gallet et al., 
2008) or an increased vagal tone (Xing et al., 2001).  
As observed, there is a complex relationship between humoral factors, neural systems (CNS 
and autonomic nervous system) and cardiac electric activity (Figure 5) and disturbances in 
these interactions may be related with the development of arrhythmias. 
 
 
Fig. 5. Schematic diagram showing the interactions between humoral factors, cardiac electric 
activity, autonomic balance and central nervous system and their role in arrhythmias 
generation. 
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6. Perspectives 
As observed, the normal control of HR depends on a complex interaction between neural 
and humoral factors and disturbances on these systems are strongly related with 
arrhythmias generation.  The formation of an action potential in the SA node and its 
propagation throughout the heart involves several ion channels, mainly Na+, K+ and Ca+2, 
and can be modulated by sympathetic and parasympathetic activation. The central outflow 
of autonomic nervous system is generated mainly in the brainstem and it involves the 
participation of diverse nuclei, such as NTS, CVLM and RVLM. The neuronal activity of 
these structures can be modulated by several hormones, including estrogen, testosterone, 
nitric oxide, angiotensin II, angiotensin (1-7), natriuretic peptides and thyroid hormones. 
Besides its effects on CNS, hormones can also regulate the release of neurotransmitters, the 
expression of ion channels and the activity of membrane transporters. Taken together, these 
data demonstrate the importance of neural and humoral systems in controlling 
cardiovascular function and brings out the possibility of new drug targets to treat 
arrhythmias. 
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